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Increasing rates of  Clostridium difficile-associated disease  (CDAD) have  been  reported from
North America since 2003. This increase is associated with the emergence and spread of a
particular  strain  of  C.  difficile  characterised as  PCR  ribotype  027  or  pulsotype  NAP1.  This
epidemic strain produces toxins A and B and the binary toxin, is resistant to erythromycin and
the newer fluoroquinolones, and patients infected with it are more likely to experience severe
disease  [1].  More  recently,  the  epidemic  PCR  ribotype  027  strain  has  spread  to  Europe.
Epidemics of C. difficile-associated disease (CDAD) due to this new, highly virulent strain have
been  detected in  England and Wales,  Ireland,  the  Netherlands,  Belgium,  Luxembourg and
France,  and  isolates  exhibiting  PCR  ribotype  027  (no  data  on  virulence-associated  traits
available) have been detected in Austria, Scotland, Switzerland, Poland, Denmark and Finland
[2-7].
In Germany, a dramatic, nationwide increase of CDAD incidence was observed between 2000
and 2004 [8,9]. However, an  association  between this increase and the occurrence of  the
epidemic PCR ribotype 027 strain has not been documented. Here, we report the isolation of C.
difficile PCR ribotype 027 from a patient suffering from pseudomembranous colitis in Germany
in March 2007. The strain was identified during a retrospective PCR ribotyping survey of stored
isolates.
Case report
In early January 2007, a 76-year-old man was admitted to a hospital in Stuttgart, in southern
Germany, for treatment of an elbow fracture. Postoperatively, the patient developed a wound
infection requiring several revisions. Following isolation of Staphylococcus aureus from a wound
swab culture, the patient was treated with amoxicillin/clavulanic acid, then later with cefalexin.
When  a  second  wound  swab  yielded  Enterobacter  cloacae  and  an  Escherichia  coli-strain-
producing extended-spectrum beta-lactamase, treatment was changed to imipenem/cilastatin.
In late March 2007, the patient developed pneumonia and severe pseudomembranous colitis.
Clostridium difficile toxins A and B were detected in a stool specimen by enzyme immuno-assay.
Three days later, the patient died from multi-organ failure and septic shock.
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Characteristics of bacterial isolate
Stool  culture  performed in  March  2007 yielded C. difficile.  Retrospectively, the  isolate  was
further characterised as PCR ribotype 027 at the reference laboratory in Leiden in August 2007.
It exhibited a heretofore undescribed MLVA genotype, and, hence, a connection with strains
circulating in the Netherlands [10] or the United States [11,12] could not be established. The
genome of the isolate contained genes for toxin A, toxin B, and binary toxin. The tcdC gene is
characterised by an 18-bp deletion  and a single nucleotide deletion at  position  117, which
causes  severe  truncation  of  the  encoded  putative  negative  regulator  of  toxin  A  and  B
production. This tcdC  genotype is typical  of the epidemic, highly virulent PCR ribotype 027
clone, first isolated in North America [11].
Using  E-tests,  the  isolate  was  determined  as  resistant  to  erythromycin,  imipenem  and
moxifloxacin, and susceptible to metronidazole, vancomycin, clindamycin and doxycyclin. This
resistance pattern has previously been reported for the epidemic PCR ribotype 027 strain. In
contrast, 'historic' PCR ribotype 027 strains isolated prior to 2001 in Europe and North America
were susceptible to moxifloxacin [1,13].
Conclusions
The highly virulent, epidemic strain of C. difficile PCR ribotype 027 was isolated from a patient
suffering from severe, antibiotic-associated CDAD in a hospital in southern Germany. There was
no indication of an outbreak situation. This report indicates that this strain was already present
in Germany in March 2007.
This  new strain  may  add to  the  increase  of  CDAD incidence  that  is  already  occurring  in
Germany. As a consequence, general practitioners’ and public health institutions’ awareness of
the incidence and severity of CDAD should be enhanced. Hygienic guidelines must be followed
to curb transmission of C. difficile, especially within hospitals and nursing homes. In case of
outbreaks and severe disease courses, bacterial isolates should be obtained from toxin-positive
faecal  samples to  enable  resistance  determination  and investigations about  possible  clonal
spread.
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